The Commission shall establish an expert group on the effect of the patenting of NGT plants (the ‘expert group’).
The expert group shall assist the Commission and exchange information on a regular basis as regards the assessment conducted by the Commission in accordance with paragraph 4 on the effect of patent law and the implementation practice on access to modified genetic resources, transparency of the patent landscape and innovation in the field of NGT plants. The expert group shall, in particular, assist the Commission on surveying the patent licensing practices for the breeding and marketing of NGT plants protected by a patent, ongoing patent application procedures concerning NGT plants and patent enforcement practices vis-à-vis farmers and, if available, examples of cases thereof.
The expert group shall be constituted in accordance with the horizontal rules on the creation and operation of Commission expert groups. Each Member State may appoint a delegation of maximum two experts to the expert group. That delegation shall have knowledge and experience in the areas covered by this Regulation and in the area of intellectual property rights, including their impact on the market. The European Patent Office and the Community Plant Variety Office may each appoint one expert to the expert group.
The Commission shall regularly assess the impact that the patenting of NGT plants, traits and techniques, as well as related licensing and transparency practices, have in the Union on:
innovation in plant breeding;
breeders’ access to patented plant biological material, traits and techniques, and breeders’ ability to conduct experimentation;
farmers’ access to plant reproductive material, including the price of available products and other commercially available propagating material, as well as their rights to use farm-saved seeds and propagating materials;
the risk of litigation involving farmers or breeders in situations where patented plant biological material may appear in their crops or products due to accidental presence or similarity, without intentional use of the patented plant biological material;
competition in the plant-breeding sector, in particular from the perspective of small and medium-sized breeders, while considering the potential risks of market concentration; and
transparency and legal certainty regarding patented plant biological material.
The first of the assessments referred to in paragraph 4 shall be conducted one year after NGT products have become available on the Union market.
The assessment referred to in paragraph 4 shall also include an evaluation of the necessary conditions to ensure that the Union breeding sector using new genomic techniques has a fair and reasonable access to patented plant biological material, exploring the possibility of granting access for free to such material.
When carrying out the assessment referred to in paragraph 4 and when considering the appropriate follow-up actions, the Commission shall take into account the findings of the expert group as well as the reporting from the Union breeding sector. To this end, the Commission shall invite the Union breeding sector to report on its experience with commercial access to patented plant biological material.
The assessment referred to in paragraph 4 shall be published and made accessible to the public.
The expert group may continue working for as long as necessary after the completion of the assessment referred to in paragraph 4.
If the assessment referred to in paragraph 4 reveals significant barriers to access to patented plant biological material, undue restrictions on experimentation, negative effects on breeders and farmers, increased market concentration, reduced diversity in seed supply, insufficient transparency, or other evidence that the system is not functioning smoothly, the Commission shall, where appropriate, submit legislative proposals to set up mandatory conditions or safeguards.
If the Commission considers that, on the basis of the assessment referred to in paragraph 4, no follow-up measures are necessary, it shall inform the European Parliament and the Council thereof and shall repeat the assessment as defined in paragraph 4 no sooner than four years and no later than six years after the publication of the first assessment.